Phase I clinical trial assessing NA 941
Latest Information Update: 12 Nov 2025
At a glance
- Drugs NA 941 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions
Most Recent Events
- 12 Nov 2025 New trial record
Latest Information Update: 12 Nov 2025